Fig. 4From: Development and identification of a prognostic nomogram model for patients with mixed cell adenocarcinoma of the ovarySurvival analysis of mixed cell adenocarcinoma, serous cystadenocarcinoma, and papillary serous cystadenocarcinoma A. Before PSM B. After PSMBack to article page